World's Best Scientists 2026 revealed!
Bjørn Tore Gjertsen

Bjørn Tore Gjertsen

D-Index & Metrics

Biology and Biochemistry

D-Index
68
Citations
15493
World Ranking
7842
National Ranking
30

Bjørn Tore Gjertsen publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Bjørn Tore Gjertsen sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 365 publications — 87th percentile

87% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Bjørn Tore Gjertsen D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Bjørn Tore Gjertsen sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 68 D-Index — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Bjørn Tore Gjertsen is affiliated with Haukeland University Hospital in Norway and has a significant publication record primarily in the fields of Medicine, and Biochemistry, Genetics and Molecular Biology. Their research focuses substantially on Hematology, with additional work in Molecular Biology, Oncology, Immunology, and Genetics.

The scientist's research topics cover areas including Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments, CAR-T cell therapy research, Chronic Lymphocytic Leukemia Research, Acute Lymphoblastic Leukemia research, Immunotherapy and Immune Responses, as well as Cancer Genomics and Diagnostics.

Frequent publication venues for Bjørn Tore Gjertsen's work include Blood, Leukemia, bioRxiv (Cold Spring Harbor Laboratory), HemaSphere, and Cancers.

Notable recent papers include the following:

  • Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia, 2021, Cancer Discovery
  • Moxetumomab pasudotox in heavily pre-treated patients with relapsed/refractory hairy cell leukemia (HCL): long-term follow-up from the pivotal trial, 2021, Journal of Hematology & Oncology
  • Bosutinib for pretreated patients with chronic phase chronic myeloid leukemia: primary results of the phase 4 BYOND study, 2020, Leukemia
  • Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: the HOVON-SAKK-132 trial, 2021, Blood Advances
  • Thrombosis and thrombocytopenia after HPV vaccination, 2021, Journal of Thrombosis and Haemostasis

Bjørn Tore Gjertsen has collaborated frequently with other researchers such as Kimmo Porkka, Jacqueline Cloos, Markus G. Manz, Bob Löwenberg, and Monica Hellesøy.

Best Publications

  • Single Cell Profiling of Potentiated Phospho-Protein Networks in Cancer Cells

    Jonathan M Irish;Randi Hovland;Peter O Krutzik;Omar D Perez

  • Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival.

    Christine Gjerdrum;Crina Tiron;Torill Høiby;Ingunn Stefansson

  • Individualized Systems Medicine Strategy to Tailor Treatments for Patients with Chemorefractory Acute Myeloid Leukemia

    Tea Pemovska;Mika Kontro;Bhagwan Yadav;Henrik Edgren

  • A human clinical trial using ultrasound and microbubbles to enhance gemcitabine treatment of inoperable pancreatic cancer

    Georg Gjorgji Dimcevski;Spiros Kotopoulis;Tormod Karlsen Bjånes;Dag Hoem

  • The protein phosphatase inhibitor okadaic acid induces morphological changes typical of apoptosis in mammalian cells.

    Roald Bøe;Bjørn Tore Gjertsen;Olav Karsten Vintermyr;Gunnar Houge

  • Inherited Mutations in PTEN That Are Associated with Breast Cancer, Cowden Disease, and Juvenile Polyposis

    Eric D. Lynch;Elizabeth A. Ostermeyer;Ming K. Lee;J. Fernando Arena

  • Rituximab for primary chronic cold agglutinin disease: a prospective study of 37 courses of therapy in 27 patients

    Sigbjørn Berentsen;Elling Ulvestad;Bjørn Tore Gjertsen;Henrik Hjorth-Hansen

  • Novel (Rp)-cAMPS analogs as tools for inhibition of cAMP-kinase in cell culture. Basal cAMP-kinase activity modulates interleukin-1 beta action.

    B T Gjertsen;G Mellgren;A Otten;E Maronde

  • Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia.

    Robert J. Kreitman;Claire Dearden;Pier Luigi Zinzani;Julio Delgado

  • SIRT1 Activation by a c-MYC Oncogenic Network Promotes the Maintenance and Drug Resistance of Human FLT3-ITD Acute Myeloid Leukemia Stem Cells

    Ling Li;Tereza Osdal;Yinwei Ho;Sookhee Chun

  • Discovery and development of the Polo-like kinase inhibitor volasertib in cancer therapy.

    Bjorn T Gjertsen;Patrick Schöffski

  • The genetic subtypes of cAMP-dependent protein kinase--functionally different or redundant?

    Stein O. Døskeland;Erik Maronde;Bjørn T. Gjertsen

  • Histone Deacetylase Inhibitors in Cancer Treatment: A Review of the Clinical Toxicity and the Modulation of Gene Expression in Cancer Cells

    O. Bruserud;C. Stapnes;E. Ersvær;B. T. Gjertsen

  • Ultrarapid caspase-3 dependent apoptosis induction by serine/threonine phosphatase inhibitors

    K. E. Fladmark;Odd Terje Brustugun;R. Hovland;R. Bøe

  • Cell therapy induced regeneration of severely atrophied mandibular bone in a clinical trial

    Cecilie Gudveig Gjerde;Kamal Babikeir Eln Mustafa;Sølve Hellem;Markus Rojewski

  • New strategies in the treatment of acute myelogenous leukemia (AML): in vitro culture of aml cells--the present use in experimental studies and the possible importance for future therapeutic approaches.

    Øystein Bruserud;Bjørn Tore Gjertsen;Brynjar Foss;Tien-Sheng Huang

  • Fine Mapping of 28S rRNA Sites Specifically Cleaved in Cells Undergoing Apoptosis

    G Houge;B Robaye;T S Eikhom;J Golstein

  • Favourable response to therapy with the anti-CD20 monoclonal antibody rituximab in primary chronic cold agglutinin disease.

    Sigbjørn Berentsen;Geir E. Tjønnfjord;Robert Brudevold;Bjørn T. Gjertsen

  • The proteasome inhibitors bortezomib and PR-171 have antiproliferative and proapoptotic effects on primary human acute myeloid leukaemia cells.

    Camilla Stapnes;Anne P. Døskeland;Kimberley Hatfield;Elisabeth Ersvær

  • Flt3-mediated signaling in human acute myelogenous leukemia (AML) blasts: a functional characterization of Flt3-ligand effects in AML cell populations with and without genetic Flt3 abnormalities

    Øystein Bruserud;Randi Hovland;Line Wergeland;Tien-Sheng Huang

Frequent Co-Authors

Øystein Bruserud
Øystein Bruserud University of Bergen
Kimmo Porkka
Kimmo Porkka University of Helsinki
Satu Mustjoki
Satu Mustjoki University of Helsinki
Stein Ove Døskeland
Stein Ove Døskeland University of Bergen
Andreas Hochhaus
Andreas Hochhaus Friedrich Schiller University Jena
Jorge E. Cortes
Jorge E. Cortes Augusta University
Olli Kallioniemi
Olli Kallioniemi Karolinska Institute
Michael Heuser
Michael Heuser Hannover Medical School
Francis J. Giles
Francis J. Giles Northwestern University
Lars A. Akslen
Lars A. Akslen University of Bergen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Bjørn Tore Gjertsen

Trending Scientists

Recently Published Articles